Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

NCT06649201 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT06649201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
Lead sponsor
Case Comprehensive Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
December 19, 2024
Completion date
February 15, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft vs host disease, vulvovaginal signs and symptoms